Avive Solutions, Inc. has secured $56.5 million in growth equity financing to enhance its innovative AED technologies and expand its market reach, aiming to improve survival rates from Sudden Cardiac Arrest.

Target Information

Avive Solutions, Inc., based in San Francisco, CA, has positioned itself as a leader in the automated external defibrillator (AED) market with its advanced product, the Avive Connect AEDⓇ. This FDA-approved device, recognized with multiple awards, is designed to enhance Sudden Cardiac Arrest (SCA) response through its state-of-the-art technology and connectivity features. Avive’s clientele includes a wide spectrum of organizations across all 50 states, such as Fortune 100 companies, federal government entities, national fitness chains, and various educational institutions.

Industry Overview

The healthcare landscape in the United States faces a significant challenge with Sudden Cardiac Arrest, leading to over 430,000 fatalities annually. As survival rates hinge on prompt defibrillation, there is an urgent need for widespread accessibility of AEDs, especially for out-of-hospital cardiac arrests. Unfortunately, only about 4% of SCA events see AED deployment prior to the arrival of emergency medical services (EMS), resulting in a nationwide survival rate stagnating at a mere 10%.

The urgency for immediate access to AEDs highlights the critical role these devices can play during the initial minutes of a cardiac emergency—where each passing minute reduces surviva